HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Baerbel Matthey Selected Research

BB 3644

9/2004Metalloproteinase inhibition augments antitumor efficacy of the anti-CD30 immunotoxin Ki-3(scFv)-ETA' against human lymphomas in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Baerbel Matthey Research Topics

Disease

1Lymphoma (Lymphomas)
09/2004
1Neoplasms (Cancer)
09/2004
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
09/2004

Drug/Important Bio-Agent (IBA)

1BB 3644IBA
09/2004
1Ki-3(scFv)-ETA'IBA
09/2004
1Immunotoxins (Immunotoxin)IBA
09/2004
1Metalloproteases (Metalloproteinases)IBA
09/2004

Therapy/Procedure

1Immunotherapy
09/2004